Does Comorbid Disruptive Behavior Modify the Effects of Atomoxetine on ADHD Symptoms as Measured by a Continuous Performance Test and a Motion Tracking Device?

Conclusion: The results showed that atomoxetine reduced ADHD severity as measured by cb-CPT and MT parameters regardless of whether comorbid ODD/CD was present. The treatment effect of atomoxetine on hyperactivity appears to be more pronounced in the subgroup of patients with comorbid ODD/CD than in the subgroup without this comorbidity.

http://jad.sagepub.com/cgi/content/abstract/19/7/591?rss=1

Source: Journal of Attention Disorders - June 16, 2015 Category: Psychiatry Authors: Wehmeier, P. M., Kipp, L., Banaschewski, T., Dittmann, R. W., Schacht, A. Tags: Articles Source Type: research